Mengmeng Ning
Impact in
- Pharmacology top 5%
- Piperaceae Chemical and Biological Studies
-
- Diabetes Treatment and Management
Papers in
- Oncology 14
- Drug Transport and Resistance Mechanisms 12
- Peptidase Inhibition and Analysis 3
-
- Diabetes Treatment and Management 11
- Co-authors
- Ying Leng (22 shared papers)Jianhua Shen (15 shared papers)Ying Feng (8 shared papers)Yangliang Ye (9 shared papers)Lina Zhang (4 shared papers)Hongliang Duan (3 shared papers)Suling Huang (4 shared papers)Ming‐Wei Wang (2 shared papers)
In The Last Decade
Mengmeng Ning
33 papers receiving 741 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 102
- Endocrinology, Diabetes and Metabolism 186
- Oncology 246
- Biochemistry 29
- Surgery 171
Countries citing papers authored by Mengmeng Ning
This map shows the geographic impact of Mengmeng Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Ning more than expected).
Fields of papers citing papers by Mengmeng Ning
This network shows the impact of papers produced by Mengmeng Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Ning. The network helps show where Mengmeng Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengmeng Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 102 | |
| 2 | 2015 | 73 | |
| 3 | 2012 | 70 | |
| 4 | 2019 | 52 | |
| 5 | 2011 | 47 | |
| 6 | 2016 | 46 | |
| 7 | 2012 | 41 | |
| 8 | 2012 | 39 | |
| 9 | 2022 | 30 | |
| 10 | 2014 | 29 | |
| 11 | 2020 | 28 | |
| 12 | 2013 | 27 | |
| 13 | 2016 | 24 | |
| 14 | 2023 | 23 | |
| 15 | 2007 | 15 | |
| 16 | 2015 | 15 | |
| 17 | 2015 | 15 | |
| 18 | 2013 | 14 | |
| 19 | 2018 | 9 | |
| 20 | 2021 | 9 |
About Mengmeng Ning
Mengmeng Ning is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery and Epidemiology, having authored 33 papers that have together received 765 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Diabetes Treatment and Management (11 papers), Receptor Mechanisms and Signaling (3 papers), Drilling and Well Engineering (3 papers), Hydraulic Fracturing and Reservoir Analysis (3 papers), Peptidase Inhibition and Analysis (3 papers), Pancreatic function and diabetes (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Pharmacology (102 citations), Endocrinology, Diabetes and Metabolism (186 citations), Oncology (246 citations), Biochemistry (29 citations) and Surgery (171 citations). Mengmeng Ning has collaborated with scholars based in China, Hungary and Japan. Frequent co-authors include Ying Leng, Jianhua Shen, Ying Feng, Yangliang Ye, Lina Zhang, Hongliang Duan, Suling Huang, Ming‐Wei Wang, Caihong Zhou and Na Li. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Acta Pharmacologica Sinica, Bioorganic & Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.